SCHEMBL23778331

SCHEMBL23778331

CCN(C(=O)O)[C@H]1CCN(C2CCC(C#N)(c3cc(C)ccn3)CC2)C1

nearest known ligand 0.37

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CCR5 P51681 4/20 0.37
KCNH2 Q12809 1/20 0.37
HRH3 Q9Y5N1 2/20 0.37
USP30 Q70CQ3 2/20 0.37
CYP2D6 P10635 1/20 0.36
CCR2 P41597 3/20 0.34
PIK3CA P42336 2/20 0.34
HSD11B1 P28845 1/20 0.34
PIK3CD O00329 1/20 0.34
PIK3CB P42338 1/20 0.34
PIK3CG P48736 1/20 0.34
KDM2B Q8NHM5 2/20 0.33
FFAR4 Q5NUL3 1/20 0.33
RAF1 P04049 1/20 0.33
BRAF P15056 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23778432 1.00 CCR5 (0.37) CCR5KCNH2HRH3USP30CYP2D6
SCHEMBL23778319 0.87 HSD11B1 (0.45) CCR5KCNH2HRH3USP30CYP2D6
SCHEMBL23778339 0.87 HSD11B1 (0.45) CCR5KCNH2HRH3USP30CYP2D6
SCHEMBL23778224 0.84 CYP2D6 (0.44) CCR5KCNH2HRH3USP30CYP2D6
SCHEMBL23778286 0.83 CCR5 (0.41) CCR5KCNH2HRH3USP30CYP2D6
SCHEMBL23778293 0.82 USP30 (0.39) CCR5KCNH2HRH3USP30CYP2D6
SCHEMBL23778248 0.82 CYP2D6 (0.43) CCR5KCNH2HRH3USP30CYP2D6
SCHEMBL23778250 0.82 USP30 (0.39) CCR5KCNH2HRH3USP30CYP2D6
SCHEMBL23778261 0.81 CYP2D6 (0.53) CCR5KCNH2HRH3USP30CYP2D6
SCHEMBL23778355 0.81 CCR2 (0.40) KCNH2USP30CYP2D6CCR2PIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109996792-B Heterocyclic compounds having activity as modulators of muscarinic M1 and/or M4 receptors in the treatment of CNS diseases and pain 赫普泰雅治疗有限公司 2023-02-17 CN claimed
EP-3526207-B1 HETEROCYCLIC COMPOUNDS HAVING ACTIVITY AS MODULATORS OF MUSCARINIC M1 AND/OR M4 RECEPTORS IN THE TREATMENT OF CNS DISEASES AND PAINS. HEPTARES THERAPEUTICS LTD (GB) 2021-09-08 EP claimed